ALL vs BNBX · P/E 4.9, rev $18.60B vs P/E 0.0, rev $2.2M
The Allstate Corporation (ALL) versus Applied DNA Sciences, Inc. (BNBX) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Applied DNA Sciences, Inc. (BNBX) is a asset management company listed on NASDAQ.
Latest reported ALL revenue for 2026-06-30 was $18.60B. Net income was $3.27B. Revenue was up 9.8% from 2026-03-31 to 2026-06-30. ALL currently screens at market cap $56.89B and trailing P/E 4.9.
Latest reported BNBX revenue for 2026-06-30 was $2.2M. Net income was -$29.9M. Revenue was up 38.1% from 2026-03-31 to 2026-06-30. BNBX currently screens at market cap $3.3M and trailing P/E 0.0.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. BNBX currently screens at market cap $3.3M and trailing P/E 0.0.
Not investment advice. Open the ALL and BNBX stock pages for the full models.
Not investment advice.